Plain-English translation of NCT05967910 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial investigates how chronic stress—the kind of ongoing emotional strain many cancer patients experience—might affect how well immunotherapy works for esophageal cancer. Researchers want to understand whether patients dealing with high stress levels respond differently to immunotherapy than those with lower stress, and whether gut bacteria changes caused by stress play a role in treatment outcomes.
While we know that stress can influence how cancer progresses in the body, doctors don't yet understand exactly how stress affects immunotherapy effectiveness in esophageal cancer patients. This study aims to fill that gap so that doctors can better support and treat patients who are managing both cancer and significant stress.
You likely qualify if…
You likely don't qualify if…
You would be part of one of four groups based on your cancer stage (early or advanced) and whether you experience chronic stress. The study involves receiving immunotherapy as your standard cancer treatment while researchers monitor your stress levels, collect tissue samples, track your treatment response, and likely study changes in your gut bacteria. You would complete questionnaires about your stress and emotional well-being alongside your regular cancer treatment appointments.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China